Belite Bio, Inc
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease (NCT06388083) | Belite Bio, Inc | 2024-07-31 |
| Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy (NCT05949593) | Belite Bio, Inc | 2023-07-27 |
| Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease (NCT05244304) | Belite Bio, Inc | 2022-03-28 |
| Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults (NCT04005807) | Belite Bio, Inc | 2019-07-19 |
Track Belite Bio, Inc automatically
Every clearance here is in the API, with alerts when new ones post.